Roche's Tecentriq combined with lurbinectedin shows significant survival benefit in extensive-stage small cell lung cancer
Basel, 3 June 2025 - Roche ( SIX: RO, ROG. OTCQX: RHHBY ) announced today positive results from the Phase III IMforte study of Tecentriq® ( atezolizumab ) in combination with lurbinectedin ( Zepzelca® ) as a first-line maintenance treatment for people with extensive-stage small cell lung cancer ( ...
Press Release: Rilzabrutinib granted orphan drug designation in the US for sickle cell disease
Rilzabrutinib granted orphan drug designation in the US for sickle cell disease ...
Addex Convenes Annual General Meeting 2025
Geneva, Switzerland, June 3, 2025 - Addex Therapeutics ( SIX: ADXN and Nasdaq: ADXN ) , a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, announced today that its 2025 Annual General Meeting will ...
Press Release: Rilzabrutinib granted orphan drug designation in the US for sickle cell disease
Rilzabrutinib granted orphan drug designation in the US for sickle cell disease Fourth orphan drug designation for rilzabrutinib in rare diseases Under regulatory review in the US, the EU, and China in immune thrombocytopenia Paris, June 3, 2025.
argenx to Present at Goldman Sachs 46th Annual Global Healthcare Conference - argenx ( NASDAQ:ARGX )
June 3, 2025 Amsterdam, the Netherlands - argenx ( ( Euronext &, NASDAQ:ARGX ) , a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that Karl Gubitz, Chief Financial Officer, will participate in a fireside chat at the ...
argenx to Present at Goldman Sachs 46th Annual Global Healthcare Conference
June 3, 2025Amsterdam, the Netherlands - argenx ( Euronext & Nasdaq: ARGX ) , a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that Karl Gubitz, Chief Financial Officer, will participate in a fireside chat at the ...
This Isn't A 'Great Sign' For Bitcoin, Says Top Currency Trader: 'Whales Are Once Again....' - Strategy ( NASDAQ:MSTR )
Influential trader Justin Bennett raised alarm over Bitcoin's BTC/USD trajectory on Monday as whales increased their short exposure against retail investors. What Happened: Bennett took to X, drawing attention to a bearish signal for the leading cryptocurrency.
Americans Are Cooking At Home More Than Ever Since COVID-And They Want Ingredients That Stretch Their Budget - The Campbell's ( NASDAQ:CPB ) , Chipotle Mexican Grill ( NYSE:CMG )
Americans are firing up their stovetops at the "highest levels since early 2020," Campbell's Co. CPB chief executive Mick Beekhuizen told analysts on Monday.
AUSTRAC Tightens Grip on Crypto ATMs After Spike in Illicit Activity
The Australian regulator has refused one crypto ATM provider's license and imposed transaction caps across the sector.
Peter Schiff Says It Was His Economic Teachings That Made People Want To Buy Bitcoin: 'An Unintended Consequence'
Peter Schiff said Monday that his teachings on economics inadvertently led many to invest in Bitcoin BTC/USD, despite his advice against it. What Happened: Schiff shared his experience at the Bitcoin 2025 conference on his YouTube podcast.